Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Images in Pratice

Immune checkpoint inhibitor-induced acute tubulointerstitial nephritis: Hui Zhuan Tan, Joycelyn Jie Xin Lee, Chon Jun Jason Choo, Alwin Hwai Liang Loh; Kidney Res Clin Pract. 2022;41(1):128-131. Published online December 29, 2021; DOI: https://doi.org/10.23876/j.krcp.21.216; Full text PubReader ePub PDF

Original Articles

Changes in metabolic parameters and adverse kidney and cardiovascular events during glomerulonephritis and renal vasculitis treatment in patients with and without diabetes mellitus: Cynthia C. Lim, Jason C. J. Choo, Hui Zhuan Tan et al.; Kidney Res Clin Pract. 2021;40(2):250-262. Published online May 21, 2021; DOI: https://doi.org/10.23876/j.krcp.20.174
Web of Science 8 Cited By 10; Full text PubReader ePub PDF Supplementary Material

Synergistic impact of pre-diabetes and immunosuppressants on the risk of diabetes mellitus during treatment of glomerulonephritis and renal vasculitis: Cynthia Ciwei Lim, Daphne Gardner, Rui Zhi Ng et al.; Kidney Res Clin Pract. 2020;39(2):172-179. Published online June 30, 2020; DOI: https://doi.org/10.23876/j.krcp.20.024
Web of Science 5 Cited By 7; Full text PubReader PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

14,831	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,812	C4d Puzzle in ABO-incompatible kidney transplantation
8,263	How should we treat acute kidney injury caused by renal congestion?
12,984	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
35,021	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.